Saint-Vincent Hospital Group, Strasbourg, France.
Cabinet of General Medicine, Strasbourg, France.
Homeopathy. 2021 Aug;110(3):168-173. doi: 10.1055/s-0040-1721065. Epub 2021 Mar 4.
The use of homeopathy in oncological supportive care seems to be progressing. The first French prevalence study, performed in 2005 in Strasbourg, showed that only 17% of the subjects were using it. What is the situation 12 years later?
This is a descriptive study, using a questionnaire identical to that used in 2005, on 633 patients undergoing treatment in three anti-cancer centers in Strasbourg. The results of the "homeopathy" sub-group were extracted and studied.
Of the 535 patients included, 164 used homeopathy: that is 30.7%. The main purpose of its use was to reduce the side effects of cancer treatments (75%). Among the users, 82.6% were "somewhat" or "very" satisfied, against "quite" satisfied for 15.5%, and "not at all" satisfied for 1.9%. The homeopathic treatment was prescribed by a doctor in 75.6% of the cases; the general practitioner was kept informed in 87% of the cases and the oncologist in 82%. Fatigue, pain, nausea, anxiety, sadness and diarrhea were improved in 80% of the cases. However, alopecia, weight disorders and loss of libido were the least improved symptoms. The use of homeopathy was significantly associated with the female sex.
With a prevalence of 30.7%, homeopathy is the most used complementary medicine in integrative oncology in Strasbourg. Over 12 years, we have witnessed an increase of 83% in its use in the same city. Almost all respondents declare themselves satisfied and tell their doctors more readily than in 2005.
顺势疗法在肿瘤支持性治疗中的应用似乎正在发展。2005 年在斯特拉斯堡进行的首次法国流行率研究表明，只有 17%的受试者在使用它。12 年后的情况如何？
这是一项描述性研究，使用了与 2005 年相同的问卷，对斯特拉斯堡三家癌症中心的 633 名接受治疗的患者进行了调查。提取并研究了“顺势疗法”亚组的结果。
在纳入的 535 名患者中，有 164 名患者使用了顺势疗法：即 30.7%。其使用的主要目的是减轻癌症治疗的副作用（75%）。在使用者中，82.6%的人“有些”或“非常”满意，而 15.5%的人“相当”满意，1.9%的人“一点也不”满意。75.6%的情况下，顺势疗法是由医生开的处方；87%的情况下，全科医生会被告知，82%的情况下肿瘤科医生会被告知。疲劳、疼痛、恶心、焦虑、悲伤和腹泻在 80%的情况下得到改善。然而，脱发、体重紊乱和性欲丧失是改善最少的症状。顺势疗法的使用与女性性别显著相关。
顺势疗法的流行率为 30.7%，是斯特拉斯堡综合肿瘤学中使用最多的补充医学。在 12 年的时间里，我们见证了它在同一城市的使用增加了 83%。几乎所有的受访者都表示满意，并比 2005 年更愿意告诉他们的医生。
